Advanced Genetic DNA Testing for Macular Degeneration
Macula Risk PGx is a combined pharmacogenetic and prognostic DNA test to determine the patient’s risk of progression to advanced AMD based on their individual genetic risk profile and to aid in the selection of appropriate eye supplement formulations for a patient diagnosed with intermediate Dry Age-related Macular Degeneration.